WuXi XDC Cayman gets GMP release for Singapore Tuas site
WuXi XDC Cayman Inc. said it received GMP release for its Singapore manufacturing site at Tuas Biomedical Park, including the BCM3 dual-function line and the DP4 facility, enabling global dual-sourcing for bioconjugate manufacturing.